CN104435636B - A kind of Chinese medicine composition for preventing paracmasis chronic bronchitis to recur - Google Patents
A kind of Chinese medicine composition for preventing paracmasis chronic bronchitis to recur Download PDFInfo
- Publication number
- CN104435636B CN104435636B CN201410734843.4A CN201410734843A CN104435636B CN 104435636 B CN104435636 B CN 104435636B CN 201410734843 A CN201410734843 A CN 201410734843A CN 104435636 B CN104435636 B CN 104435636B
- Authority
- CN
- China
- Prior art keywords
- parts
- grams
- chinese medicine
- paracmasis
- chronic bronchitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 58
- 206010006451 bronchitis Diseases 0.000 title claims abstract description 32
- 206010006458 Bronchitis chronic Diseases 0.000 title claims abstract description 31
- 208000007451 chronic bronchitis Diseases 0.000 title claims abstract description 31
- 239000000203 mixture Substances 0.000 title claims abstract description 22
- 235000006753 Platycodon grandiflorum Nutrition 0.000 claims abstract description 18
- 240000003582 Platycodon grandiflorus Species 0.000 claims abstract description 18
- 244000226566 Psoralea corylifolia Species 0.000 claims abstract description 18
- PXFBZOLANLWPMH-UHFFFAOYSA-N 16-Epiaffinine Natural products C1C(C2=CC=CC=C2N2)=C2C(=O)CC2C(=CC)CN(C)C1C2CO PXFBZOLANLWPMH-UHFFFAOYSA-N 0.000 claims abstract description 16
- 235000015763 Artemisia ludoviciana Nutrition 0.000 claims abstract description 16
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims abstract description 16
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 16
- 244000194101 Ginkgo biloba Species 0.000 claims abstract description 16
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 16
- 241000608847 Gnaphalium Species 0.000 claims abstract description 16
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 16
- 241001312530 Pimpinella thellungiana Species 0.000 claims abstract description 16
- 241001165494 Rhodiola Species 0.000 claims abstract description 16
- 241000219784 Sophora Species 0.000 claims abstract description 16
- 210000003954 umbilical cord Anatomy 0.000 claims abstract description 16
- 240000000950 Hippophae rhamnoides Species 0.000 claims abstract description 15
- 241000471262 Ardisia japonica Species 0.000 claims abstract description 14
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 14
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 14
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims abstract description 14
- 235000017443 Hedysarum boreale Nutrition 0.000 claims abstract description 14
- 235000007858 Hedysarum occidentale Nutrition 0.000 claims abstract description 14
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims abstract description 14
- 241000432824 Asparagus densiflorus Species 0.000 claims abstract description 13
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims abstract description 11
- 230000002265 prevention Effects 0.000 claims abstract description 10
- 229940079593 drug Drugs 0.000 claims abstract description 9
- 240000008620 Fagopyrum esculentum Species 0.000 claims abstract 4
- 230000002708 enhancing effect Effects 0.000 abstract description 7
- 230000036039 immunity Effects 0.000 abstract description 7
- 230000008901 benefit Effects 0.000 abstract description 3
- 210000004072 lung Anatomy 0.000 description 34
- 210000000952 spleen Anatomy 0.000 description 25
- 206010011224 Cough Diseases 0.000 description 24
- 239000008280 blood Substances 0.000 description 20
- 206010062717 Increased upper airway secretion Diseases 0.000 description 18
- 208000026435 phlegm Diseases 0.000 description 18
- 210000003734 kidney Anatomy 0.000 description 17
- 210000004369 blood Anatomy 0.000 description 16
- 241000219051 Fagopyrum Species 0.000 description 12
- 235000009508 confectionery Nutrition 0.000 description 11
- 230000007812 deficiency Effects 0.000 description 11
- 201000010099 disease Diseases 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 9
- 208000006673 asthma Diseases 0.000 description 8
- 208000011580 syndromic disease Diseases 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 6
- 206010036790 Productive cough Diseases 0.000 description 6
- 230000003110 anti-inflammatory effect Effects 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- 230000001154 acute effect Effects 0.000 description 4
- 230000001684 chronic effect Effects 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 230000036407 pain Effects 0.000 description 4
- 210000003800 pharynx Anatomy 0.000 description 4
- 210000003802 sputum Anatomy 0.000 description 4
- 208000024794 sputum Diseases 0.000 description 4
- 241000432767 Asparagus setaceus Species 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 241001065361 Gynostemma Species 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 230000002929 anti-fatigue Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 206010002660 Anoxia Diseases 0.000 description 2
- 241000976983 Anoxia Species 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000007953 anoxia Effects 0.000 description 2
- 230000000767 anti-ulcer Effects 0.000 description 2
- 230000003727 cerebral blood flow Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000001076 estrogenic effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000002443 hepatoprotective effect Effects 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- 238000002310 reflectometry Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 238000002636 symptomatic treatment Methods 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- FQEQMASDZFXSJI-RWMBFGLXSA-N (-)-Anagyrine Natural products C([C@@H]12)CCCN1C[C@H]1C3=CC=CC(=O)N3C[C@@H]2C1 FQEQMASDZFXSJI-RWMBFGLXSA-N 0.000 description 1
- JLTCWSBVQSZVLT-CDIPANDDSA-N (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1.C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 JLTCWSBVQSZVLT-CDIPANDDSA-N 0.000 description 1
- LOTKRQAVGJMPNV-UHFFFAOYSA-N 1-fluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C([N+]([O-])=O)=C1 LOTKRQAVGJMPNV-UHFFFAOYSA-N 0.000 description 1
- XVPBINOPNYFXID-JARXUMMXSA-N 85u4c366qs Chemical compound C([C@@H]1CCC[N@+]2(CCC[C@H]3[C@@H]21)[O-])N1[C@@H]3CCCC1=O XVPBINOPNYFXID-JARXUMMXSA-N 0.000 description 1
- FQEQMASDZFXSJI-UHFFFAOYSA-N Anagyrin Natural products C12CCCCN2CC2C3=CC=CC(=O)N3CC1C2 FQEQMASDZFXSJI-UHFFFAOYSA-N 0.000 description 1
- 206010002953 Aphonia Diseases 0.000 description 1
- LFYJSSARVMHQJB-UHFFFAOYSA-N Backuchiol Natural products CC(C)=CCCC(C)(C=C)C=CC1=CC=C(O)C=C1 LFYJSSARVMHQJB-UHFFFAOYSA-N 0.000 description 1
- 229930008564 C01BA04 - Sparteine Natural products 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000000094 Chronic Pain Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000008265 Favism Diseases 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- 206010018444 Glucose-6-phosphate dehydrogenase deficiency Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000229143 Hippophae Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 102000005320 Posterior Pituitary Hormones Human genes 0.000 description 1
- 108010070873 Posterior Pituitary Hormones Proteins 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 240000005319 Sedum acre Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- AAGFPTSOPGCENQ-UHFFFAOYSA-N Sophocarpin I Natural products C1CCC2CN3C(=O)C=CCC3C3C2N1CCC3 AAGFPTSOPGCENQ-UHFFFAOYSA-N 0.000 description 1
- IGXQFUGORDJEST-UHFFFAOYSA-N Sophocarpine Natural products O=C1C=CCC2C3CCCC4CCCC(CN12)C34 IGXQFUGORDJEST-UHFFFAOYSA-N 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 241001646984 Thamnolia Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009798 acute exacerbation Effects 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- SLRCCWJSBJZJBV-UHFFFAOYSA-N alpha-isosparteine Natural products C1N2CCCCC2C2CN3CCCCC3C1C2 SLRCCWJSBJZJBV-UHFFFAOYSA-N 0.000 description 1
- FQEQMASDZFXSJI-YNEHKIRRSA-N anagyrine Chemical compound C([C@@H]12)CCCN1C[C@H]1C3=CC=CC(=O)N3C[C@H]2C1 FQEQMASDZFXSJI-YNEHKIRRSA-N 0.000 description 1
- ICFWMXKHGNCJTK-UHFFFAOYSA-N anagyrine Natural products O=C1C=CC=C2C3CC(CC4CCCCN4C3)N12 ICFWMXKHGNCJTK-UHFFFAOYSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001772 anti-angiogenic effect Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- LFYJSSARVMHQJB-GOSISDBHSA-N bakuchinol Natural products CC(C)=CCC[C@@](C)(C=C)C=CC1=CC=C(O)C=C1 LFYJSSARVMHQJB-GOSISDBHSA-N 0.000 description 1
- LFYJSSARVMHQJB-QIXNEVBVSA-N bakuchiol Chemical compound CC(C)=CCC[C@@](C)(C=C)\C=C\C1=CC=C(O)C=C1 LFYJSSARVMHQJB-QIXNEVBVSA-N 0.000 description 1
- 229940117895 bakuchiol Drugs 0.000 description 1
- KXXXNMZPAJTCQY-UHFFFAOYSA-N bakuchiol Natural products CC(C)CCCC(C)(C=C)C=Cc1ccc(O)cc1 KXXXNMZPAJTCQY-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 230000008576 chronic process Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000007368 endocrine function Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 229940068052 ginkgo biloba extract Drugs 0.000 description 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 210000005096 hematological system Anatomy 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000037111 immune power Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 208000001286 intracranial vasospasm Diseases 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000011224 negative regulation of urine volume Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 229930015582 oxymatrine Natural products 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229930189407 platycodin Natural products 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- AAGFPTSOPGCENQ-JLNYLFASSA-N sophocarpine Chemical compound C1CC[C@H]2CN3C(=O)C=CC[C@@H]3[C@@H]3[C@H]2N1CCC3 AAGFPTSOPGCENQ-JLNYLFASSA-N 0.000 description 1
- SLRCCWJSBJZJBV-AJNGGQMLSA-N sparteine Chemical compound C1N2CCCC[C@H]2[C@@H]2CN3CCCC[C@H]3[C@H]1C2 SLRCCWJSBJZJBV-AJNGGQMLSA-N 0.000 description 1
- 229960001945 sparteine Drugs 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 208000027930 type IV hypersensitivity disease Diseases 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/487—Psoralea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8965—Asparagus, e.g. garden asparagus or asparagus fern
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Nutrition Science (AREA)
- Insects & Arthropods (AREA)
- Physiology (AREA)
- Hematology (AREA)
- Reproductive Health (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of Chinese medicine composition for preventing paracmasis chronic bronchitis to recur, the Chinese medicine composition is made up of following bulk drug：Umbilical cord, psoralea corylifolia, pimpinella thellungiana, asparagus fern, Radix changii, gynostemma pentaphylla, rhodiola root, sea-buckthorn, affine cudweed, ardisia japonica, subprostrate sophora, cymose buckwheat rhizome, ginkgo leaf, balloonflower root, honey-fried licorice root, honeycomb.The Chinese medicine composition for the prevention paracmasis chronic bronchitis recurrence that the present invention is provided, with enhancing immunity of organisms, the advantage of preventing chronic bronchitis recurrence is the special-purpose medicaments of paracmasis preventing chronic bronchitis recurrence.
Description
Technical field
The present invention relates to Chinese medicine sciemtifec and technical sphere, more particularly to a kind of Chinese medicine group for preventing paracmasis chronic bronchitis to recur
Compound.
Background technology
Chronic bronchitis refers to the chronic nonspecific inflammation of trachea-bronchial epithelial cell mucous membrane and its surrounding tissue.Clinically
To cough, expectoration or with panting and the chronic process of recurrent exerbation is characterized.Chronic bronchitis is a kind of serious harm people
Common disease, the frequently-occurring disease of people's health, it is especially common with the elderly, and the incidence of disease is in rising trend.Its fall ill mainly with respiratory tract office
Portion's defence and immunologic hypofunction, respiratory tract infection, smoking, allergic reaction, climate change, irritating chemical factors etc. are abnormal
Factor is relevant, easy recurrent exerbation.Research at present for chronic bronchitis is not also thorough, single doctor trained in Western medicine or Chinese traditional treatment,
Each advantageous and limitation.Acute stage, the treatment based on Western medicine such as typically takes anti-inflammatory, cough-relieving, relievings asthma with infection control.Alleviate
The treatment of phase, mainly avoids the high risk factor of morbidity, induces the factor and enhancing immunity of organisms of acute exacerbation.But it is clinical
In curative activity, the patient of chronic bronchitis paracmasis is general without effective treatment, thus causes the disease long-term repeatedly
Breaking-out, touching refractory present situation.The principle of traditional Chinese medicine " symptomatic treatment in acute condition, radical treatment in chronic case " is followed, in paracmasis active treatment,
Developing the Chinese medicine composition of prevention paracmasis chronic bronchitis recurrence has important clinical significance.
The content of the invention
It is an object of the invention to overcome in the presence of prior art above-mentioned not enough there is provided one kind prevention paracmasis is chronic
The Chinese medicine composition of bronchitis recurrence.
In order to realize foregoing invention purpose, the invention provides following technical scheme：
A kind of Chinese medicine composition for preventing paracmasis chronic bronchitis to recur, is made up of the bulk drug of following mass ratio
Medicament：4~8 parts of umbilical cord, 9~15 parts of psoralea corylifolia, 12~18 parts of pimpinella thellungiana, 8~12 parts of asparagus fern, 9~15 parts of Radix changii, strand
Blue 10~20 parts, 8~12 parts of rhodiola root, 6~10 parts of sea-buckthorn, 8~12 parts of affine cudweed, 20~30 parts of ardisia japonica, subprostrate sophora 4~8
Part, 25~35 parts of cymose buckwheat rhizome, 8~12 parts of ginkgo leaf, 6~10 parts of balloonflower root, 4~8 parts of honey-fried licorice root, 2~4 parts of honeycomb.
The pharmacological action of Chinese medicine of the present invention is as follows：
Umbilical cord：Sweet, salty, temperature, returns kidney channel.Kidney tonifying, receives gas, arrest sweating.Treat the diseases such as dyspnea and cough due to deficiency of the kidney, night sweat.Umbilical cord has female
Hormone-like effect, and body immunity can be strengthened.
Psoralea corylifolia：Bitter, pungent, temperature, returns kidney, the spleen channel.Tonifying kidney and strengthening yang, astringent sperm contracting urine is warming spleen and stopping diarrha, and gas of receiving is relievingd asthma.Cure mainly kidney
Empty impotence, waist and knee crymodynia；Emission due to the kidney deficiency, the enuresis, frequent micturition；Insufficiency of both the spleen and the kindey Diarrhoea；The failure of the kidney in receiving air, the cold of insufficiency type is breathed with cough.Psoralea corylifolia
There is significant protective effect to chmice acute myocardial ischemia caused by pituitrin；Psoralea corylifolia is received to the tracheae as caused by histamine
Contracting has obvious dilating effect；Bakuchiol has estrogen-like action, can strengthen vagina angling, strengthens uterus weight；Psoralea corylifolia leads to
Nerve and hematological system are overregulated, promotes marrow hemopoiesis, enhancing is immunized and endocrine function, so as to play anti-aging effects.
Pimpinella thellungiana：Pungent, sweet, temperature, the thoughts of returning home, kidney, lung, the spleen channel.Warming kidney and enhancing yang, promoting blood circulation and removing blood stasis, mental-tranquilization, warming lung for dispelling cold.
Cure mainly impotence not lift, defective ejaculation cold sperm；Qi depression to blood stasis, chest impediment and cardialgia；Palpitation and insomnia, shortness of breath uncomfortable in chest；Catch cold, drink cough of trembling with fear.
Pimpinella thellungiana can strengthen the activity of cardiac muscle and brain tissue respiratory enzyme；There is obvious antihypertensive effect, and with certain strong effect.
Asparagus fern：It is sweet, bitter, cold, return lung, kidney, stomach.Nourishing yin to moisten dryness, clearing lung-heat is promoted the production of body fluid.Cure mainly syndrome of deficiency of lung yin；Syndrome of deficiency of kidney yin；Heat
Disease hinders the card such as the poor appetite in Tianjin, thirsty and dry constipation of intestines.Asparagus fern can increase peripheral vascular expansion, drop in blood pressure, contractile force
By force, decreased heart rate and urine volume increase.
Radix changii：Sweet, slight bitter, it is slightly cold, return lung, spleen, Liver Channel.Moistening lung for removing phlegm, yin-nourishing and stomach, soothing the liver.Cure mainly syndrome of deficiency of lung yin；
Syndrome of yin deficiency of spleen and stomach；Attacked on deficiecny of liver-YIN or liver heat the card such as dizziness, headache, hot eyes extremely.Radix changii can reduce experimental animal
Serum cholesterol, improves the ratio of HDL and cholesterol, increases serum superoxide dismutase, reduction serum the third two
Aldehyde；Mouse spleen lymphocyte NK activity can be improved, suppresses the delayed hypersensitivity reaction caused by dinitrofluorobenzene；It is also resistance to lack
Oxygen, high temperature resistance, fatigue-resisting function.
Gynostemma pentaphylla：It is sweet, bitter, cold, returns spleen, lung channel.Replenish qi to invigorate the spleen, preventing phlegm from forming and stopping coughing is clearing heat and detoxicating.Cure mainly syndrome of spleen deficiency, the deficiency syndrome of the lung
Cough card.Gynostemma pentaphylla has antifatigue, anti anoxia, high temperature resistance, low-temperature resistance effect；Nospecific immunity, cell can substantially be increased
The immune, function of humoral immunity, and tool immunoregulation effect；With obvious reducing blood lipid, hypoglycemic effect, and spleen can be improved
The synthesis rate of dirty, testis, brain and hematoglobin protein；And there is calmness, hypnosis, analgesia, increase coronary flow, anti-cardiac muscle to lack
The effects such as blood, increase cerebral blood flow (CBF), inhibition thrombosis, liver protection, antiulcer.
Rhodiola root：It is sweet, cold, returns spleen, lung channel.Strengthening the spleen and replenishing qi, it is promoting blood circulation and removing blood stasis.Rhodiola root is longer than treatment Spleen-Qi Deficiency and declined, burnout
It is weak to wait the blood stasis symptoms such as disease, and traumatic injury.It has antifatigue, anti anoxia, cold resistance, improves the effect such as operating efficiency.
Sea-buckthorn：Sweet, sour, temperature, returns spleen, stomach, lung, the heart channel of Hang-Shaoyin.Reinforcing spleen to promote digestion, cough-relieving apophlegmatic, promoting blood circulation.Cure mainly insufficiency of the spleen food
It is few, coughing with a lot of sputum, blood stasis symptom.Hippophate flavone has improvement Myocardial Microcirculation, reduces myocardial oxygen consumption, anti-angiogenic hardening, anti-inflammatory etc.
Effect；Seabuckthorn Oil and its fruit juice can be with antifatigue, reducing blood lipid, radioresistance, antiulcer, liver protection and enhancing immunologic functions.
Affine cudweed：It is sweet, slightly sour, flat, return lung warp.Preventing phlegm from forming and stopping coughing, dispelling wind and eliminating dampness, removing toxic substances.Cure mainly cough and phlegm, rheumatism numbness
Bitterly, diarrhea, oedema, favism, leukorrhea with reddish discharge, carbuncle swells furunculosis, scrotum is wet to itch, nettle rash, hypertension.Affine cudweed have antibechic,
Bacteriostasis.
Ardisia japonica：It is bitter, pungent, flat, return lung, Liver Channel.Relieving cough and asthma, eliminating dampness and heat is promoting blood circulation and removing blood stasis.Cure mainly cough and asthma；Damp and hot Huang
Subcutaneous ulcer, oedema；Blood stasis, arthralgia pain due to rheumatism, traumatic injury.Ardisia japonica has obvious cough-relieving, eliminating the phlegm, bacteriostasis；And convection current is susceptible
Poison has certain inhibitory action.
Subprostrate sophora：It is bitter, cold, poisonous, attach to the lung and stomach meridians.It is clearing heat and detoxicating, reducing pharyngeal swelling.Cure mainly abscess of throat, swelling and aching of gum.
Subprostrate sophora has bacteriostasis；Its contained anagyrine, sparteine energy reflectivity ground excited breathing, oxymatrine and sophocarpine
There is stronger antiasthmatic effect；In addition, subprostrate sophora also has rise white blood cell, antiarrhythmic effect, antiinflammatory action and hepatoprotective effect.
Cymose buckwheat rhizome：Micro-pungent, puckery, cool, return lung warp.It is clearing heat and detoxicating, apocenosis dissolving stasis.Cure mainly lung carbuncle, cough with lung heat；Scrofula sore
Furuncle, abscess of throat.Cymose buckwheat rhizome has the effect such as eliminating the phlegm, antipyretic, anti-inflammatory, antitumor.
Ginkgo leaf：It is bitter, puckery, flat.Astringe the lung and relieving asthma, promoting blood circulation and stopping pain.For deficiency syndrome of the lung cough and asthma, and high fat of blood, hypertension, coronary disease
Sick angina pectoris, cerebral angiospasm etc..Ginkgo leaf main component is GINKGO BILOBA EXTRACT.
Balloonflower root：It is bitter, pungent, flat, return lung warp.Facilitaing lung, eliminating the phlegm, relieving sore-throat, apocenosis.Coughing with a lot of sputum is cured mainly, it is uncomfortable in chest not smooth；Throat swells
Bitterly, aphonia；Lung carbuncle pyemesis.Platycodin contained by balloonflower root to oral cavity, throat, gastric mucosa direct stimulation, reflectivity
Increase tunica mucosa bronchiorum hypersecretion so that sputum dilutes, it is easy to discharge；Balloonflower root has antitussive effect, has enhancing anti-inflammatory and immune
Power is acted on；The thick saponin(e of balloonflower root has calm, analgesia, refrigeration function, and can hypoglycemic, norcholesterol, relaxing smooth muscle.
Honey-fried licorice root:It is sweet, flat, the thoughts of returning home, lung, spleen, stomach.Invigorate the spleen and benefit qi, expelling phlegm and arresting coughing, relieving spasm to stop pain is clearing heat and detoxicating, reconcile
All medicines.Cure mainly deficiency of heart-QI, intermittent pulse, severe palpilation；Syndrome of deficiency of spleen qi；Cough and asthma；Gastral cavity abdomen, four limbs contraction；Mediation property of medicine.Radix glycyrrhizae
There are anti-inflammatory, antiallergy, antidiuresis, lipid-loweringing, hepatoprotective effect, also estrogenic activity.
Honeycomb：It is sweet, flat, return stomach.Detoxicating and destroying parasites, wind-expelling pain-stopping.Treatment of ulcer pyogenic infections, acute mastitis, scrofula, stubborn dermatitis itch,
Cancerous swelling；Arthralgia pain due to rheumatism, toothache, rubella itch.Honeycomb is equal to acute and chronic inflammation to be suppressed, and analgesic activity is then main to chronic
Pain is effective；Also it is depressured, expands blood vessel and cardiotonic；And can anticancer, antibacterial and cooling.
Chronic bronchitis belongs to the categories such as traditional Chinese medicine " cough ".Traditional Chinese medicine thinks its occurrence and development and lung, spleen, kidney
Three dirty functional disturbances and decline have extremely close relationship, are the card of " weakened body resistance evil volt ".The weakened body resistance yang-energy that focuses on is weak, in lung then
Perverse trend is easily violated and coughed, and in spleen, then wet compotation stops into phlegm, is then lost in kidney and receives and be to breathe heavily；It is weakened body resistance, perverse trend easy entry and difficulty is dispelled, phlegm
It is turbid to accumulate lung, blood is then entered by gas long, volt lung network in the phlegm-blood stasis blood of place, so-called " place phlegm-blood stasis blood, it is disease to hinder gas ", and often because of exopathogen priming or
Strongly fragrant longization heat, satisfies into acute attack or protracted course of disease.Bronchus pathology damage is difficult to repair, when the paracmasis is the key for the treatment of
Machine, it then follows the principle of traditional Chinese medicine " symptomatic treatment in acute condition, radical treatment in chronic case ", the place phlegm-blood stasis blood washed in lung is searched in the paracmasis, helps it empty
The yang-energy declined, makes lung, spleen, the visceral-qiization of kidney three normal again, is to control chronic bronchitis feelings, prevention recurrence, the base for improving curative effect
This therapy.The present invention is tonified the kidney to improve inspiration using umbilical cord, psoralea corylifolia, pimpinella thellungiana, improves immunity of organisms；Asparagus fern, Radix changii yin-nourishing profit
It is dry, clearing lung and eliminating phlegm；Gynostemma pentaphylla, rhodiola root, sea-buckthorn replenish qi to invigorate the spleen, preventing phlegm from forming and stopping coughing, promoting blood circulation；Affine cudweed, ardisia japonica cough-relieving are put down
Breathe heavily；Subprostrate sophora, cymose buckwheat rhizome are clearing heat and detoxicating；Ginkgo leaf, which is astringed the lung, relievings asthma；Balloonflower root clearing lung and eliminating the phlegm；Honey-fried licorice root is invigorated the spleen and benefited qi, expelling phlegm and arresting coughing,
Coordinating the drug actions of a prescription；Honeycomb washs clearly the place phlegm-blood stasis blood of lung network.All medicines share, kidney tonifying, invigorating the spleen, clearing lung-heat improve immunity of organisms to control
" sheet "；And resolving sputum, facilitaing lung, dissolving stasis are to control " mark ".
It is preferred that, the Chinese medicine composition for preventing the recurrence of paracmasis chronic bronchitis is by the raw material of following mass ratio
The medicament that medicine is made：5~7 parts of umbilical cord, 11~13 parts of psoralea corylifolia, 14~16 parts of pimpinella thellungiana, 9~11 parts of asparagus fern, Radix changii 11~1
3 parts, 13~17 parts of gynostemma pentaphylla, 9~11 parts of rhodiola root, 7~9 parts of sea-buckthorn, 9~11 parts of affine cudweed, 23~27 parts of ardisia japonica, mountain beans
5~7 parts of root, 28~32 parts of cymose buckwheat rhizome, 9~11 parts of ginkgo leaf, 7~9 parts of balloonflower root, 5~7 parts of honey-fried licorice root, 2~4 parts of honeycomb.
It is further preferred that the Chinese medicine composition of the prevention paracmasis chronic bronchitis recurrence is by following mass ratio
The medicament that is made of bulk drug：6 parts of umbilical cord, 12 parts of psoralea corylifolia, 15 parts of pimpinella thellungiana, 10 parts of asparagus fern, 12 parts of Radix changii, gynostemma pentaphylla 15
Part, 10 parts of rhodiola root, 8 parts of sea-buckthorn, 10 parts of affine cudweed, 25 parts of ardisia japonica, 6 parts of subprostrate sophora, 30 parts of cymose buckwheat rhizome, 10 parts of ginkgo leaf,
8 parts of balloonflower root, 6 parts of honey-fried licorice root, 3 parts of honeycomb.
The Chinese medicine composition of the prevention paracmasis chronic bronchitis recurrence can use existing Chinese medicine preparation technique system
It is standby for example said components using decocting to be obtained water decoction into any conventional oral preparations, can also be by other existing
The Chinese medicine composition of the prevention paracmasis chronic bronchitis recurrence is prepared piece agent, water-honeyed pill, glue by Chinese medicine preparation technology
Wafer, powder, paste, oral liquid, granule.
Compared with prior art, beneficial effects of the present invention
The Chinese medicine composition for the prevention paracmasis chronic bronchitis recurrence that the present invention is provided, with enhancing immunity of organism
Power, the advantage of preventing chronic bronchitis recurrence is the special-purpose medicaments for preventing the recurrence of paracmasis chronic bronchitis.
A kind of Chinese medicine composition for preventing paracmasis chronic bronchitis to recur, clinical efficacy is summarized
1 general information
In 48 patients, man 31, female 17;Age 42 ~ 75, average (61.21 ± 7.34) year;The course of disease is most long by 23
Year, it is most short 3 years;Severity extent:Slight 4, moderate 31, severe 13.All patients are all in the paracmasis.
2 diagnostic criteria
Reference《Practical clinical practice》Diagnostic criteria（Chen Haozhu practicalities clinical practice Beijing：People's Health Publisher, 2002：
1548.）.Clinically using cough, expectoration as cardinal symptom or with panting, annual morbidity continues 3 months and continuous 2 years or more
Diagnosable disease, but annual morbidity continues the patient less than 3 months, if any clear and definite objective determination foundation（Such as x-ray, PFT
Deng）Also it is diagnosable.
3 treatment methods
6 grams of umbilical cord, 12 grams of psoralea corylifolia, 15 grams of pimpinella thellungiana, 10 grams of asparagus fern, 12 grams of Radix changii, 15 grams of gynostemma pentaphylla, rhodiola root 10
Gram, 8 grams of sea-buckthorn, 10 grams of affine cudweed, 25 grams of ardisia japonica, 6 grams of subprostrate sophora, 30 grams of cymose buckwheat rhizome, 10 grams of ginkgo leaf, 8 grams of balloonflower root, process it is sweet
Water decoction is made according to conventional Chinese medicine preparation technology in 6 grams of grass, 3 grams of honeycomb, everyone one portion per day.
4 treatment results
4.1 observation index：1. patient's AECB number of times in 1 year before treating, after treatment.2. treat
Before, treatment 10 weeks when peripheral blood serum IgG, IgA and IgM indexs.
4.2 result：Treated through 10 weeks, treat patient's AECB 5.11 ± 2.24 times in first 1 year；
Broken out 2.71 ± 1.32 times in 1 year after treatment, difference is statistically significant（P<0.01）.The change of IgG, IgA and IgM index is shown in attached
Table, IgG, IgA and IgM are significantly improved before all relatively treating, and difference is statistically significant（P<0.05）.
Subordinate list：Before treatment, treatment 10 weeks when IgG, IgA and IgM index change
| Number of cases | IgG | IgA | IgM | |
| Before treatment | 48 | 2.43±0.68 | 1.72±0.49 | 10.49±2.57 |
| After treatment | 48 | 2.89±0.91 | 1.99±0.82 | 13.54±2.68 |
Embodiment
With reference to embodiment, the present invention is described in further detail.But this should not be interpreted as to the present invention
The scope of above-mentioned theme is only limitted to following embodiment, all models that the present invention is belonged to based on the technology that present invention is realized
Enclose.
Embodiment 1, a kind of Chinese medicine composition for preventing paracmasis chronic bronchitis to recur, is by 8 grams of umbilical cord, psoralea corylifolia
15 grams, 18 grams of pimpinella thellungiana, 12 grams of asparagus fern, 15 grams of Radix changii, 20 grams of gynostemma pentaphylla, 12 grams of rhodiola root, 10 grams of sea-buckthorn, affine cudweed 12
Gram, 30 grams of ardisia japonica, 8 grams of subprostrate sophora, 35 grams of cymose buckwheat rhizome, 12 grams of ginkgo leaf, 10 grams of balloonflower root, 8 grams of honey-fried licorice root, 4 grams of honeycomb, according to
Water decoction is made in conventional Chinese medicine preparation technology, everyone one portion per day.
Embodiment 2, a kind of Chinese medicine composition for preventing paracmasis chronic bronchitis to recur, is by 7 grams of umbilical cord, psoralea corylifolia
13 grams, 16 grams of pimpinella thellungiana, 11 grams of asparagus fern, 13 grams of Radix changii, 17 grams of gynostemma pentaphylla, 11 grams of rhodiola root, 9 grams of sea-buckthorn, 11 grams of affine cudweed,
27 grams of ardisia japonica, 7 grams of subprostrate sophora, 32 grams of cymose buckwheat rhizome, 11 grams of ginkgo leaf, 9 grams of balloonflower root, 7 grams of honey-fried licorice root, 4 grams of honeycomb, according to routine
Water decoction is made in Chinese medicine preparation technology, everyone one portion per day.
Embodiment 3, a kind of Chinese medicine composition for preventing paracmasis chronic bronchitis to recur, is by 6 grams of umbilical cord, psoralea corylifolia
12 grams, 15 grams of pimpinella thellungiana, 10 grams of asparagus fern, 12 grams of Radix changii, 15 grams of gynostemma pentaphylla, 10 grams of rhodiola root, 8 grams of sea-buckthorn, 10 grams of affine cudweed,
25 grams of ardisia japonica, 6 grams of subprostrate sophora, 30 grams of cymose buckwheat rhizome, 10 grams of ginkgo leaf, 8 grams of balloonflower root, 6 grams of honey-fried licorice root, 3 grams of honeycomb, according to routine
Water decoction is made in Chinese medicine preparation technology, everyone one portion per day.
Embodiment 4, a kind of Chinese medicine composition for preventing paracmasis chronic bronchitis to recur, is by 5 grams of umbilical cord, psoralea corylifolia
11 grams, it is 14 grams of pimpinella thellungiana, 9 grams of asparagus fern, 11 grams of Radix changii, 13 grams of gynostemma pentaphylla, 9 grams of rhodiola root, 7 grams of sea-buckthorn, 9 grams of affine cudweed, short
23 grams of thamnolia vermicularia, 5 grams of subprostrate sophora, 28 grams of cymose buckwheat rhizome, 9 grams of ginkgo leaf, 7 grams of balloonflower root, 5 grams of honey-fried licorice root, 2 grams of honeycomb, according in routine
Water decoction is made in medicine preparation technique, everyone one portion per day.
Embodiment 5, a kind of Chinese medicine composition for preventing paracmasis chronic bronchitis to recur, is by 4 grams of umbilical cord, psoralea corylifolia
9 grams, it is 12 grams of pimpinella thellungiana, 8 grams of asparagus fern, 9 grams of Radix changii, 10 grams of gynostemma pentaphylla, 8 grams of rhodiola root, 6 grams of sea-buckthorn, 8 grams of affine cudweed, short
20 grams of tea, 4 grams of subprostrate sophora, 25 grams of cymose buckwheat rhizome, 8 grams of ginkgo leaf, 6 grams of balloonflower root, 4 grams of honey-fried licorice root, 2 grams of honeycomb, according to conventional Chinese medicine
Water decoction is made in preparation technique, everyone one portion per day.
Claims (3)
1. a kind of Chinese medicine composition for preventing paracmasis chronic bronchitis to recur, it is characterised in that by following mass ratio
The medicament that bulk drug is made：
4~8 parts of umbilical cord, 9~15 parts of psoralea corylifolia, 12~18 parts of pimpinella thellungiana, 8~12 parts of asparagus fern, 9~15 parts of Radix changii, gynostemma pentaphylla
10~20 parts, 8~12 parts of rhodiola root, 6~10 parts of sea-buckthorn, 8~12 parts of affine cudweed, 20~30 parts of ardisia japonica, 4~8 parts of subprostrate sophora,
25~35 parts of cymose buckwheat rhizome, 8~12 parts of ginkgo leaf, 6~10 parts of balloonflower root, 4~8 parts of honey-fried licorice root, 2~4 parts of honeycomb.
2. as claimed in claim 1 prevention the paracmasis chronic bronchitis recurrence Chinese medicine composition, it is characterised in that by with
The medicament that the bulk drug of lower mass ratio is made：
5~7 parts of umbilical cord, 11~13 parts of psoralea corylifolia, 14~16 parts of pimpinella thellungiana, 9~11 parts of asparagus fern, 11~13 parts of Radix changii, strand
Blue 13~17 parts, 9~11 parts of rhodiola root, 7~9 parts of sea-buckthorn, 9~11 parts of affine cudweed, 23~27 parts of ardisia japonica, subprostrate sophora 5~7
Part, 28~32 parts of cymose buckwheat rhizome, 9~11 parts of ginkgo leaf, 7~9 parts of balloonflower root, 5~7 parts of honey-fried licorice root, 2~4 parts of honeycomb.
3. as claimed in claim 1 prevention the paracmasis chronic bronchitis recurrence Chinese medicine composition, it is characterised in that by with
The medicament that the bulk drug of lower mass ratio is made：
6 parts of umbilical cord, 12 parts of psoralea corylifolia, 15 parts of pimpinella thellungiana, 10 parts of asparagus fern, 12 parts of Radix changii, 15 parts of gynostemma pentaphylla, 10 parts of rhodiola root,
8 parts of sea-buckthorn, 10 parts of affine cudweed, 25 parts of ardisia japonica, 6 parts of subprostrate sophora, 30 parts of cymose buckwheat rhizome, 10 parts of ginkgo leaf, 8 parts of balloonflower root, honey-fried licorice root 6
Part, 3 parts of honeycomb.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410734843.4A CN104435636B (en) | 2014-12-08 | 2014-12-08 | A kind of Chinese medicine composition for preventing paracmasis chronic bronchitis to recur |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410734843.4A CN104435636B (en) | 2014-12-08 | 2014-12-08 | A kind of Chinese medicine composition for preventing paracmasis chronic bronchitis to recur |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104435636A CN104435636A (en) | 2015-03-25 |
| CN104435636B true CN104435636B (en) | 2017-07-21 |
Family
ID=52882897
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410734843.4A Expired - Fee Related CN104435636B (en) | 2014-12-08 | 2014-12-08 | A kind of Chinese medicine composition for preventing paracmasis chronic bronchitis to recur |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104435636B (en) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103784625B (en) * | 2014-01-28 | 2016-08-31 | 李鸣娟 | A kind of Chinese medicine composition treating chronic bronchitis |
-
2014
- 2014-12-08 CN CN201410734843.4A patent/CN104435636B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN104435636A (en) | 2015-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105412858A (en) | Syrup and preparation method thereof | |
| CN102688384A (en) | Traditional Chinese medicine decoction for treating chronic pharyngitis | |
| CN104288477A (en) | Traditional Chinese medicine preparation curing infantile asthma | |
| CN104623583A (en) | Asthenia cold abdominalgia treating drug and preparation method of asthenia cold abdominalgia treating drug oral liquid | |
| CN104435636B (en) | A kind of Chinese medicine composition for preventing paracmasis chronic bronchitis to recur | |
| CN106581585A (en) | Medicine composition for treating gastric ulcer | |
| CN103110905A (en) | Traditional Chinese medical preparation for treating cholecystitis with stagnation of liver qi and spleen deficiency | |
| CN103877397B (en) | A kind of medicine of radiotherapy injury of lung and preparation method | |
| CN103202940A (en) | Antiphlogistic drug | |
| CN1410105A (en) | Zibei Cough stopping granules and its preparation method | |
| CN101129543A (en) | Chinese ephedra Huagai powder | |
| CN1277578C (en) | Medicine for treating lung disease, preparing method for medicine and preparation | |
| CN105311602B (en) | A kind of Chinese medicine composition of prevention asthma in children | |
| CN115252732B (en) | Traditional Chinese medicine composition for clearing lung and relieving cough and application thereof | |
| CN104162119A (en) | Traditional Chinese medicine for treating children's exogenous cough | |
| CN116549595B (en) | Pharmaceutical composition for treating functional dyspepsia of children, preparation and application thereof | |
| CN103463236B (en) | Medicinal composition and preparation method thereof | |
| CN105560790A (en) | Pharmaceutical preparation for treating and preventing pharyngitis and application thereof | |
| CN105250613A (en) | Medicine for treating chronic obstructive pulmonary disease in stable phase | |
| CN105395782A (en) | Preparation method of aerosol inhalation medicine for treating chronic obstructive pulmonary disease | |
| CN105853882A (en) | Medicine for treating stomach illness and preparation method | |
| CN105687779A (en) | Cough and asthma relieving particle and preparation method thereof | |
| CN105920497A (en) | Medicine for treating gastropathy and preparation method thereof | |
| CN105288195A (en) | Medicine for treating thyroiditis and preparation method for medicine | |
| CN105125973A (en) | Traditional Chinese medicine preparation for treating infantile bronchitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB03 | Change of inventor or designer information | ||
| CB03 | Change of inventor or designer information |
Inventor after: Xu Xinhua Inventor after: Du Xiaohong Inventor after: Xu Jinrong Inventor before: Zhang Fenghua Inventor before: Liu Jinwei Inventor before: Zhong Gengai |
|
| TA01 | Transfer of patent application right | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20170623 Address after: 262500 Shandong city of Weifang province Qingzhou City Linglong Mountain Road No. 3888 Qingzhou Invalides hospital Applicant after: Xu Xinhua Applicant after: Du Xiaohong Address before: 262500 Qingzhou, Weifang Linglong Hill Road, No. 4138, No. Applicant before: Zhang Fenghua |
|
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20170721 Termination date: 20171208 |